Partial Nephrectomy is the Surgical Treatment of Choice for (Most) Complex Localized Renal Tumors

IF 1.1 Q4 ONCOLOGY Kidney Cancer Pub Date : 2018-08-01 DOI:10.3233/KCA-180039
A. Herlemann, A. Herlemann, A. Odisho, S. Porten
{"title":"Partial Nephrectomy is the Surgical Treatment of Choice for (Most) Complex Localized Renal Tumors","authors":"A. Herlemann, A. Herlemann, A. Odisho, S. Porten","doi":"10.3233/KCA-180039","DOIUrl":null,"url":null,"abstract":"The decision to undergo partial nephrectomy (PN) versus radical nephrectomy (RN) for a localized renal mass should take various factors into consideration, including tumor characteristics, patient’s health status and preference, and risks and benefits of these each approach. PN represents a suitable surgical approach for small renal tumors in favorable locations. It may also better preserve long-term renal function, particularly in patients who may need surgery for a contralateral kidney mass or have preexisting chronic kidney disease. Conversely, RN may be preferred in elderly patients with severe (non-renal related) comorbidities, in patients with an anatomically challenging tumor location, or for larger or locally advanced masses. The presentation and management of renal tumors has changed substantially during the last few decades. The increasing use and quality of crosssectional imaging has been associated with increased incidence, earlier detection and improved staging of renal masses [12]. Most kidney tumors are now diagnosed incidentally in asymptomatic patients [3]. In a recent study by Welch et al. examining a large cohort of Medicare beneficiaries, increase rates of computed tomography (CT) imaging was associated with","PeriodicalId":17823,"journal":{"name":"Kidney Cancer","volume":" ","pages":""},"PeriodicalIF":1.1000,"publicationDate":"2018-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3233/KCA-180039","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Kidney Cancer","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3233/KCA-180039","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

The decision to undergo partial nephrectomy (PN) versus radical nephrectomy (RN) for a localized renal mass should take various factors into consideration, including tumor characteristics, patient’s health status and preference, and risks and benefits of these each approach. PN represents a suitable surgical approach for small renal tumors in favorable locations. It may also better preserve long-term renal function, particularly in patients who may need surgery for a contralateral kidney mass or have preexisting chronic kidney disease. Conversely, RN may be preferred in elderly patients with severe (non-renal related) comorbidities, in patients with an anatomically challenging tumor location, or for larger or locally advanced masses. The presentation and management of renal tumors has changed substantially during the last few decades. The increasing use and quality of crosssectional imaging has been associated with increased incidence, earlier detection and improved staging of renal masses [12]. Most kidney tumors are now diagnosed incidentally in asymptomatic patients [3]. In a recent study by Welch et al. examining a large cohort of Medicare beneficiaries, increase rates of computed tomography (CT) imaging was associated with
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
肾部分切除术是(大多数)复杂局限性肾肿瘤的手术治疗选择
对于局限性肾脏肿块,决定接受部分肾切除术(PN)还是根治性肾切除术(RN)应考虑各种因素,包括肿瘤特征、患者的健康状况和偏好,以及每种方法的风险和益处。PN代表了在有利位置治疗小型肾肿瘤的合适手术方法。它还可以更好地保持长期肾功能,特别是对于可能需要对侧肾肿块手术或已有慢性肾脏疾病的患者。相反,RN可能更适合患有严重(非肾脏相关)合并症的老年患者、具有解剖挑战性肿瘤位置的患者,或较大或局部晚期肿块的患者。在过去的几十年里,肾脏肿瘤的表现和治疗发生了很大的变化。横断面成像的使用和质量的提高与肾脏肿块的发病率增加、早期发现和分期改善有关[12]。大多数肾脏肿瘤现在都是在无症状患者中偶然诊断出来的[3]。在Welch等人最近的一项研究中,对一大群联邦医疗保险受益人进行了检查,计算机断层扫描(CT)成像率的增加与
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Kidney Cancer
Kidney Cancer Multiple-
CiteScore
0.90
自引率
8.30%
发文量
23
期刊最新文献
Emerging Antibody-Drug Conjugate Therapies and Targets for Metastatic Renal Cell Carcinoma Genomic and Transcriptomic Characteristics of Tumors of Patients with Metastatic Clear Cell Renal Cell Carcinoma Clinically Benefiting from First-Line Treatment with Ipilimumab Plus Nivolumab Nephrotoxicity Associated with Contemporary Renal Cell Carcinoma Regimens: A Systematic Review and Meta-Analysis Targeted Literature Review of Outcomes to Initial Systemic Therapy for Advanced/Metastatic Non-Clear Cell Renal Cell Carcinoma in Observational Studies Fibrinogen Levels in Patients with Metastatic Renal Cell Carcinoma Treated with Nivolumab: Results of a Multicenter Prospective Trial
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1